Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC22A17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C4BPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLP1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIGLEC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EFCAB13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC16A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL31RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAHD2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLGN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GREB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKCSH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR8071-2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC730268 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMO6P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on